Edition:
United States

Health News Headlines

Retrophin scraps nervous system disorder study, shares dive

Retrophin Inc said on Thursday it was discontinuing the late-stage study for its rare neurological disorder treatment after it failed to improve patients' ability to conduct daily activities such as eating and walking, sending shares down 30%.

Politics Video

Politics News

Key dates in the U.S.-China trade war

Hopes for settlement of the yearlong U.S.-China trade war dimmed further on Friday as China said it will slap retaliatory tariffs on about $75 billion worth of U.S. goods, the latest escalation in the dispute between the world's two largest economies.